Dutasteride + Minoxidil+ dermaroller/dermastamp appreciation post Progress Pictures 11/11/2024
The user has been using finasteride, dutasteride, minoxidil, and a dermaroller/dermastamp for hair loss, reporting positive results and no significant side effects. They switched from finasteride to dutasteride for better results and apply topical minoxidil despite having braids.
View this post in the Community β
Similar Community Posts Join
5 / 5 resultscommunity 7 months of Topical Minoxidil and oral finasteride. Switched to 1 month dutasteride.
The user has been using topical Minoxidil and oral finasteride for 7 months and switched to dutasteride for 1 month, seeking better results. They are also looking for oral Minoxidil from Thailand and considering using a dermaroller or dermastamp.
community βOne year birthday. Finasteride and minoxidil and derma roller, ketosol shampoo, omega 3, biotin, exercise every day. and joy of life.
A user shared their one-year progress using finasteride, minoxidil, derma roller, ketosol shampoo, omega 3, biotin, daily exercise, and a positive outlook. They also discussed their exercise routine and addressed a question about finasteride side effects.
community 4 months of topical minoxidil with derma rolling starting at month 2 - my review / experience
The user has been using topical minoxidil and dermarolling for hair regrowth but is hesitant to start finasteride due to potential side effects. Many suggest adding finasteride for better results in addressing DHT-related hair loss.
community 5 months on finasteride - 1 year on minoxidil comparison day 1 vs now
The user has been using minoxidil 5% twice daily for a year and finasteride 0.5 mg daily for five months, seeing noticeable hair growth without side effects. They are considering adding microneedling with a derma roller or stamp to their routine for enhanced results.
community Minoxidil + Fin 1 mg + Dermaroller 1x week - 1 year results
A user used Minoxidil twice daily, 1 mg finasteride in the morning, and a dermaroller weekly for a year but is unhappy with the results and sperm quality. Others suggest continuing the regimen, noting hair maintenance and thickness, and considering additional treatments like dutasteride or a hair transplant.
Related Research
6 / 6 results
research Safety concerns when using novel medications to treat alopecia
This review discusses the safety concerns associated with new treatments for non-scarring alopecias, highlighting that while these therapies such as JAK inhibitors and oral minoxidil show efficacy in hair regrowth, their safety profiles vary significantly, requiring careful consideration of benefits and risks.
research Female Androgenetic Alopecia: An Update on Diagnosis and Management
This review discusses female androgenetic alopecia, highlighting its diagnostic challenges and management strategies, but it reports no new results.
research Phytochemicals as emerging therapeutic agents for alopecia treatment
This chapter provides an overview of phytochemicals with properties to combat alopecia and discusses the potential of flavonoids, found in several herbs, as a safer alternative to synthetic hair loss treatments due to their long-term skin compatibility.
research Minimally Invasive Non-Surgical Therapies for Androgenetic Alopecia: A Narrative Review of Clinical Evidence for Regenerative and Locally Acting Antiandrogen Treatments
This study reviewed evidence for six minimally invasive treatments for androgenetic alopecia, finding consistent support for platelet-rich plasma and topical finasteride, while other options like microneedling and intradermal dutasteride showed promise but need further and standardized research.
research Managing patterned hair loss β a hair raising task!
This review summarizes existing knowledge on diffuse and patterned alopecia, emphasizing recent advancements in treatment beyond FDA-approved options, but it reports no new clinical findings.
research Hair Restoration in Androgenetic Alopecia: Looking Beyond Minoxidil, Finasteride and Hair Transplantation
This review discusses the emerging pathophysiological factors and potential new therapies for androgenetic alopecia beyond traditional treatments, but reports no new results.